Whole Exome Sequencing in South Africa: Stakeholder Views on Return of Individual Research Results and Incidental Findings
暂无分享,去创建一个
[1] Jared O'Connell,et al. A population-specific reference panel for improved genotype imputation in African Americans , 2021, Communications Biology.
[2] Shunmin He,et al. NyuWa Genome resource: A deep whole-genome sequencing-based variation profile and reference panel for the Chinese population. , 2021, Cell reports.
[3] W. Chung,et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.
[4] Andreas Henschel,et al. A Population-Specific Major Allele Reference Genome From The United Arab Emirates Population , 2021, Frontiers in Genetics.
[5] William T. Harvey,et al. Haplotype-resolved diverse human genomes and integrated analysis of structural variation , 2021, Science.
[6] G. Paré,et al. Whole exome sequencing reveals a biallelic frameshift mutation in GRXCR2 in hearing impairment in Cameroon , 2021, Molecular genetics & genomic medicine.
[7] A. Wonkam. Sequence three million genomes across Africa , 2021, Nature.
[8] I. Munabi,et al. Researchers’ perspectives on return of individual genetics results to research participants: a qualitative study , 2021, Global bioethics = Problemi di bioetica.
[9] Heng Li,et al. The design and construction of reference pangenome graphs with minigraph , 2020, Genome biology.
[10] R. Wilkinson,et al. Human whole genome sequencing in South Africa , 2020, bioRxiv.
[11] M. Kotze,et al. Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing , 2020, Frontiers in Genetics.
[12] S. Soddu,et al. Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers , 2020, Journal of Experimental & Clinical Cancer Research.
[13] Shuyang Zhang,et al. A call for global action for rare diseases in Africa , 2019, Nature Genetics.
[14] R. Dorrington,et al. Burden of disease in South Africa: Protracted transitions driven by social pathologies. , 2019, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[15] K. Kinoshita,et al. Construction and integration of three de novo Japanese human genome assemblies toward a population-specific reference , 2019, bioRxiv.
[16] J. de Vries,et al. Returning incidental findings in African genomics research , 2019, Nature Genetics.
[17] Hongyu Zhao,et al. HUPAN: a pan-genome analysis pipeline for human genomes , 2019, Genome Biology.
[18] G. Mazandu,et al. Dissecting in silico Mutation Prediction of Variants in African Genomes: Challenges and Perspectives , 2019, Front. Genet..
[19] K. Ormond,et al. The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results. , 2019, American journal of human genetics.
[20] A. Krause. New genetic testing technologies: Advantages and limitations , 2019, South African Medical Journal.
[21] Scott M. Williams,et al. The Missing Diversity in Human Genetic Studies , 2019, Cell.
[22] A. Dobin,et al. Is it time to change the reference genome? , 2019, bioRxiv.
[23] Alicia R. Martin,et al. The critical needs and challenges for genetic architecture studies in Africa. , 2018, Current opinion in genetics & development.
[24] D. MacArthur,et al. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy , 2017, Orphanet Journal of Rare Diseases.
[25] Lars Bolund,et al. Sequencing and de novo assembly of 150 genomes from Denmark as a population reference , 2017, Nature.
[26] C. Klaver,et al. Whole-Exome Sequencing Identifies Biallelic IDH3A Variants as a Cause of Retinitis Pigmentosa Accompanied by Pseudocoloboma. , 2017, Ophthalmology.
[27] Monique M. Ryan,et al. Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy , 2017, Annals of clinical and translational neurology.
[28] M. Kotze,et al. Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway , 2017, International journal of molecular sciences.
[29] Clara Gaff,et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement , 2017, Genetics in Medicine.
[30] W. Chung,et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.
[31] Rolf Schröder,et al. Clinical exome sequencing: results from 2819 samples reflecting 1000 families , 2016, European Journal of Human Genetics.
[32] Jefferey Chen,et al. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing. , 2016, The Journal of molecular diagnostics : JMD.
[33] A. Swaroop,et al. Molecular Diagnosis of Inherited Retinal Diseases in Indigenous African Populations by Whole-Exome Sequencing , 2016, Investigative ophthalmology & visual science.
[34] Zachary A. Szpiech,et al. Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry , 2016, Nature Communications.
[35] Michael Parker,et al. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies , 2016, Genetics in Medicine.
[36] Y. Joly,et al. Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views , 2016, BMC Medical Genomics.
[37] Mahmoud Zirie,et al. The Qatar genome: a population-specific tool for precision medicine in the Middle East , 2016, Human Genome Variation.
[38] Michelle D. Brazas,et al. Continuing Education Workshops in Bioinformatics Positively Impact Research and Careers , 2016, PLoS Comput. Biol..
[39] J. Mullikin,et al. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants. , 2016, Clinical chemistry.
[40] Anke M Hövels,et al. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability , 2016, Genetics in Medicine.
[41] D. Stein,et al. Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents , 2015, Journal of Medical Ethics.
[42] Si Quang Le,et al. Building Population-Specific Reference Genomes: A Case Study of Vietnamese Reference Genome , 2015, 2015 Seventh International Conference on Knowledge and Systems Engineering (KSE).
[43] L. Ehler,et al. Considering Actionability at the Participant's Research Setting Level for Anticipatable Incidental Findings from Clinical Research , 2015, Journal of Law, Medicine & Ethics.
[44] F. Zou,et al. Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center’s Experience , 2015, Front. Pediatr..
[45] Jonathan S Berg,et al. Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. , 2015, American journal of human genetics.
[46] S. Sisodiya. Genetic screening and diagnosis in epilepsy? , 2015, Current opinion in neurology.
[47] Avni Santani,et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification , 2015, Genome research.
[48] Jennifer B. McCormick,et al. Patients' views on incidental findings from clinical exome sequencing , 2015, Applied & translational genomics.
[49] M. Farrer,et al. Disease penetrance of late-onset parkinsonism: a meta-analysis. , 2014, JAMA neurology.
[50] Magalie S Leduc,et al. Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.
[51] W. Newman,et al. Delivery of a Clinical Genomics Service , 2014, Genes.
[52] A. Kerasidou. SHARING THE KNOWLEDGE: SHARING AGGREGATE GENOMIC FINDINGS WITH RESEARCH PARTICIPANTS IN DEVELOPING COUNTRIES , 2014, Developing world bioethics.
[53] N. Hallowell,et al. Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues , 2014, Journal of Medical Ethics.
[54] Jean-Baptiste Cazier,et al. Choice of transcripts and software has a large effect on variant annotation , 2014, Genome Medicine.
[55] Eric Vilain,et al. Assessing the necessity of confirmatory testing for exome sequencing results in a clinical molecular diagnostic laboratory , 2014, Genetics in Medicine.
[56] W. Kibbe,et al. Review of Current Methods, Applications, and Data Management for the Bioinformatics Analysis of Whole Exome Sequencing , 2014, Cancer informatics.
[57] Christian Gilissen,et al. A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases , 2013, Human mutation.
[58] K. Ormond. From genetic counseling to “genomic counseling” , 2013, Molecular genetics & genomic medicine.
[59] Susan M Wolf,et al. Return of individual research results and incidental findings: facing the challenges of translational science. , 2013, Annual review of genomics and human genetics.
[60] Lin Huang,et al. Short read alignment with populations of genomes , 2013, Bioinform..
[61] R. Green,et al. Attitudes about regulation among direct-to-consumer genetic testing customers. , 2013, Genetic testing and molecular biomarkers.
[62] Darragh G. McArt,et al. Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis , 2013, PloS one.
[63] S. Wyatt,et al. Counseling Customers: Emerging Roles for Genetic Counselors in the Direct-to-Consumer Genetic Testing Market , 2013, Journal of Genetic Counseling.
[64] J. Lawn,et al. Health in South Africa: changes and challenges since 2009 , 2012, The Lancet.
[65] Kris Dierickx,et al. To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts , 2012, European Journal of Human Genetics.
[66] Adam Kiezun,et al. Exome sequencing and the genetic basis of complex traits , 2012, Nature Genetics.
[67] Christopher A Cassa,et al. Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility. , 2012, Genome research.
[68] J. Herring,et al. “Please Don’t Tell Me” , 2011, Cambridge Quarterly of Healthcare Ethics.
[69] Omar E. Cornejo,et al. Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence , 2011, PLoS genetics.
[70] Muin J Khoury,et al. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.
[71] Edwin Cuppen,et al. Disclosure of individual genetic data to research participants: the debate reconsidered. , 2011, Trends in genetics : TIG.
[72] Joanna Smith,et al. Qualitative data analysis: the framework approach. , 2011, Nurse researcher.
[73] George Church,et al. Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants: Updated Guidelines from a National Heart, Lung, and Blood Institute Working Group , 2010, Circulation. Cardiovascular genetics.
[74] Frances P Lawrenz,et al. Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations , 2008, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
[75] A. McGuire,et al. Research ethics and the challenge of whole-genome sequencing , 2008, Nature Reviews Genetics.
[76] P. Sainsbury,et al. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[77] J. Weil. Genetic counselling in the era of genomic medicine , 2002, EMBO reports.
[78] A. Clark. To tell or not to tell , 2001, BMJ : British Medical Journal.
[79] Z. M. Manyisa,et al. Factors affecting working conditions in public hospitals: A literature review , 2017 .
[80] E. Ashkinadze,et al. 125: Whole exome sequencing (WES) in prenatal diagnosis for carefully selected cases , 2017 .
[81] E. Murphy,et al. A response to 'Quality in qualitative evaluation: a framework for assessing research evidence' , 2004 .